Neuromuscular pharmacology. A clinical update and commentary.
D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D002800:Cholinesterase Inhibitors / Q000494:pharmacology; D004347:Drug Interactions; D004558:Electric Stimulation; D006024:Glycopyrrolate / Q000494:pharmacology; D006801:Humans; D007231:Infant, Newborn; D007676:Kidney Failure, Chronic / Q000378:metabolism; D007700:Kinetics; D008107:Liver Diseases / Q000378:metabolism; D008991:Monitoring, Physiologic; D009119:Muscle Contraction / Q000187:drug effects; D009466:Neuromuscular Blocking Agents / Q000097:blood / Q000494:pharmacology; D009469:Neuromuscular Junction / Q000187:drug effects* / Q000502:physiology; D009765:Obesity / Q000378:metabolism; D013390:Succinylcholine / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects
D000900:Anti-Bacterial Agents; D002800:Cholinesterase Inhibitors; D009466:Neuromuscular Blocking Agents; D013390:Succinylcholine; D006024:Glycopyrrolate